Literature DB >> 20586001

Does surfactant type cause a differential proinflammatory response in preterm infants with respiratory distress syndrome?

Vanessa V Mercado1, Ioana Cristea, Noorjahan Ali, Chau Chau Pham, Elizabeth Buescher, Jean Yang, Joie Fisher, Hima Maramreddy, Johanna Calo, Sonya Strassberg, Lance A Parton.   

Abstract

INTRODUCTION: The objective of this study was to compare the pulmonary inflammatory response of premature infants with respiratory distress following instillation of one of two commonly available surfactant preparations.
METHODS: This was a prospective, randomized investigation of preterm infants who were less than 30 weeks of gestational age, weighed less than 1 kg at birth, and who qualified to receive surfactant. Infants with multiple congenital anomalies or whose mothers were taking anti-inflammatory medications were ineligible. Tracheal aspirates (TAs) were collected on days 1, 3, 5, and 7 and airway cytokines from TAs were assayed for interleukin (IL)-8 and IL-6.
RESULTS: Infants were evenly matched by gestation (26+/-2 days and 26+/-1 days [mean+/-SD], Surfactant A and B, respectively) and birth weight (730+/-141 g and 732+/-167 g). TA cytokine levels were not different between or within groups. Ventilator requirements and clinical outcomes were similar between the two groups.
CONCLUSION: The postnatal airway inflammatory response observed in preterm infants is not altered by the instillation of either surfactant preparation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20586001     DOI: 10.1007/s12325-010-0044-3

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  6 in total

Review 1.  Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants.

Authors:  Neetu Singh; Henry L Halliday; Timothy P Stevens; Gautham Suresh; Roger Soll; Maria Ximena Rojas-Reyes
Journal:  Cochrane Database Syst Rev       Date:  2015-12-21

2.  Eligibility Criteria and Representativeness of Randomized Clinical Trials That Include Infants Born Extremely Premature: A Systematic Review.

Authors:  Leeann R Pavlek; Brian K Rivera; Charles V Smith; Joanie Randle; Cory Hanlon; Kristi Small; Edward F Bell; Matthew A Rysavy; Sara Conroy; Carl H Backes
Journal:  J Pediatr       Date:  2021-04-21       Impact factor: 6.314

Review 3.  Beractant and poractant alfa in premature neonates with respiratory distress syndrome: a systematic review of real-world evidence studies and randomized controlled trials.

Authors:  Manuel Sánchez Luna; Peter Bacher; Kristina Unnebrink; Marisol Martinez-Tristani; Cristina Ramos Navarro
Journal:  J Perinatol       Date:  2020-02-12       Impact factor: 2.521

4.  Porcine vs bovine surfactant therapy for preterm neonates with RDS: systematic review with biological plausibility and pragmatic meta-analysis of respiratory outcomes.

Authors:  Ascanio Tridente; Lucia De Martino; Daniele De Luca
Journal:  Respir Res       Date:  2019-02-06

5.  Porcine versus bovine surfactant therapy for RDS in preterm neonates: pragmatic meta-analysis and review of physiopathological plausibility of the effects on extra-pulmonary outcomes.

Authors:  Silvia Foligno; Daniele De Luca
Journal:  Respir Res       Date:  2020-01-07

6.  Early Immunomodulatory Effects of Different Natural Surfactant Preparations in Preterms With Respiratory Distress.

Authors:  Mehmet Yalaz; Sema Tanriverdi; Özgün Uygur; Özge Altun Köroğlu; Elif Azarsiz; Guzide Aksu; Nilgün Kültürsay
Journal:  Front Pediatr       Date:  2022-03-18       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.